Organigram Global Inc. (OGI) to Acquire Aurora for C$561M
Organigram (OGI) will acquire Aurora for C$561M, or C$7.80 per share, a 93% premium over Aurora's August 2026 price. The deal, pending approvals, is expected to close in January 2027. It follows Aurora's review of Curaleaf's hostile bid.
How this was made

The 30-second read
Why it matters
The deal is expected to reshape market dynamics in the Canadian cannabis industry, with immediate price impacts for both companies.
Market read
First‑report M&A of over $400 M in the cannabis sector, likely to move both stocks sharply.
What to watch
Regulatory approvals and potential integration challenges could delay value realization.
Background
Organigram Global Inc. disclosed a definitive agreement to acquire Aurora Cannabis, offering a substantial premium and targeting a January 2027 close.
Market effects
Consolidation in the Canadian cannabis sector may spur further M&A activity.
Canadian cannabis stocks could see broader price adjustments as the deal sets a new valuation benchmark.
The transaction highlights continued investor interest in the global cannabis market.
Counterpoint
The high premium could strain Organigram's balance sheet and dilute existing shareholders.
Key entities
- AcquirerOrganigram Global Inc.
Canadian cannabis company expanding through acquisition.
- TargetAurora Cannabis Inc.
Canadian cannabis producer being bought at a premium.


